Edition:
United Kingdom

People: Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

4.41USD
7:48pm BST
Change (% chg)

$-0.09 (-1.89%)
Prev Close
$4.49
Open
$4.52
Day's High
$4.53
Day's Low
$4.38
Volume
64,132
Avg. Vol
358,170
52-wk High
$10.44
52-wk Low
$3.51

Faulkingham, Dell 

Mr. Dell Faulkingham is Senior Vice President, Chief Commercial Officer of the Company. He joins the company with more than 20 years of commercial experience across a broad range of specialty pharmaceutical categories. His experience includes commercial leadership roles with Biogen Inc., where he held multiple positions of increasing responsibility, most recently serving as Senior Vice President and Head, U.S. Multiple Sclerosis (MS) Franchise. Mr. Faulkingham also recently served as Vice President, Head of U.S. MS Marketing and Field Operations at Biogen. Prior to joining Biogen, Mr. Faulkingham held several roles with Takeda Pharmaceuticals. Mr. Faulkingham began his career in sales at Forest Pharmaceuticals, Inc. and received a B.S. in biology from the University of Georgia.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams

133,436

John Butler

3,471,070

Jason Amello

1,091,020

Nicole Hadas

--

Steven Burke

--

Michel Dahan

1,276,790
As Of  31 Dec 2018